CervoMed Inc expected to post a loss of 66 cents a share - Earnings Preview

CervoMed

10/05/2025 01:26

CervoMed Inc CRVO.OQ CRVO.O is expected to show a fall in quarterly revenue when it reports  results on May 12 (estimated) for the period ending March 31 2025

The Boston Massachusetts-based  company is expected to report a 26.6% decrease in revenue to $1.722 million from $2.35 million a year ago, according to the mean estimate from 5 analysts, based on LSEG data.

‚ÄčLSEG's mean analyst estimate for CervoMed Inc is for a loss of 66 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts had fallen by about 5.8% in the last three months. ‚Äč

Wall Street's median 12-month price target for CervoMed Inc is $15.00‚Äč, above‚Äč its last closing price of $8.49. ‚Äč‚Äč‚Äč

Previous quarterly performance (using preferred earnings measure in US dollars). ‚Äč

QUARTER ENDING
STARMINESMARTESTIMATE¬ģ
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Dec. 31 2024
-0.68
-0.63
-0.80
Missed
-27
Sep. 30 2024
-0.40
-0.41
-0.55
Missed
-33.3
Jun. 30 2024
-0.26
-0.31
-0.27
Beat
11.8‚Äč
Mar. 31 2024
-0.39
-0.39
-0.41
Missed
-5.1
‚Äč‚ÄčDec. 31 2023
-0.29
-0.29
-0.38
Missed
-31
Sep. 30 2023
-0.95
-0.95
-0.70
Beat
26.3‚Äč

This summary was machine generated May 10 at 00:26 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)